Alcoholic-Hepatitis, Links to Brain and Microbiome: Mechanisms, Clinical and Experimental Research
Open Access
- 18 March 2020
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 8 (3), 63
- https://doi.org/10.3390/biomedicines8030063
Abstract
The following review article presents clinical and experimental features of alcohol-induced liver disease (ALD). Basic aspects of alcohol metabolism leading to the development of liver hepatotoxicity are discussed. ALD includes fatty liver, acute alcoholic hepatitis with or without liver failure, alcoholic steatohepatitis (ASH) leading to fibrosis and cirrhosis, and hepatocellular cancer (HCC). ALD is fully attributable to alcohol consumption. However, only 10–20% of heavy drinkers (persons consuming more than 40 g of ethanol/day) develop clinical ALD. Moreover, there is a link between behaviour and environmental factors that determine the amount of alcohol misuse and their liver disease. The range of clinical presentation varies from reversible alcoholic hepatic steatosis to cirrhosis, hepatic failure, and hepatocellular carcinoma. We aimed to (1) describe the clinico-pathology of ALD, (2) examine the role of immune responses in the development of alcoholic hepatitis (ASH), (3) propose diagnostic markers of ASH, (4) analyze the experimental models of ALD, (5) study the role of alcohol in changing the microbiota, and (6) articulate how findings in the liver and/or intestine influence the brain (and/or vice versa) on ASH; (7) identify pathways in alcohol-induced organ damage and (8) to target new innovative experimental concepts modeling the experimental approaches. The present review includes evidence recognizing the key toxic role of alcohol in ALD severity. Cytochrome p450 CYP2E1 activation may change the severity of ASH. The microbiota is a key element in immune responses, being an inducer of proinflammatory T helper 17 cells and regulatory T cells in the intestine. Alcohol consumption changes the intestinal microbiota and influences liver steatosis and liver inflammation. Knowing how to exploit the microbiome to modulate the immune system might lead to a new form of personalized medicine in ALF and ASH.Keywords
This publication has 150 references indexed in Scilit:
- Lysine acetylation induced by chronic ethanol consumption impairs dynamin-mediated clathrin-coated vesicle releaseHepatology, 2011
- Regression of established hepatocellular carcinoma is induced by chemoimmunotherapy in an orthotopic murine modelHepatology, 2011
- Clinical Characteristics and Mortality of Hospitalized Alcoholic Hepatitis Patients in the United StatesJournal of Clinical Gastroenterology, 2011
- Enteric dysbiosis associated with a mouse model of alcoholic liver diseaseHepatology, 2010
- The role of cytokines in UbD promoter regulation and Mallory-Denk body-like aggresomesExperimental and Molecular Pathology, 2010
- Consequences of Motor Copy Number on the Intracellular Transport of Kinesin-1-Driven Lipid DropletsCell, 2008
- The Gregarious Lipid DropletOnline Journal of Public Health Informatics, 2008
- Microtubule acetylation and stability may explain alcohol-induced alterations in hepatic protein traffickingHepatology, 2007
- Histone H3 phosphorylation at serine 10 and serine 28 is mediated by p38 MAPK in rat hepatocytes exposed to ethanol and acetaldehyde⁎European Journal of Pharmacology, 2007
- Distinct methylation patterns in histone H3 at Lys-4 and Lys-9 correlate with up- & down-regulation of genes by ethanol in hepatocytesLife Sciences, 2007